Liquan Wu

1.3k total citations · 1 hit paper
27 papers, 984 citations indexed

About

Liquan Wu is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Liquan Wu has authored 27 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Genetics and 6 papers in Oncology. Recurrent topics in Liquan Wu's work include Glioma Diagnosis and Treatment (6 papers), Cancer Cells and Metastasis (3 papers) and Neurological Disease Mechanisms and Treatments (3 papers). Liquan Wu is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Cancer Cells and Metastasis (3 papers) and Neurological Disease Mechanisms and Treatments (3 papers). Liquan Wu collaborates with scholars based in China, United States and South Korea. Liquan Wu's co-authors include Xiaoxing Xiong, Xiaomin Wu, Zhi Zeng, Zhihong Jian, Yingze Ye, Lijuan Gu, Xiang Zeng, Talita Glaser, Inbo Han and Baohui Liu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Brain Research.

In The Last Decade

Liquan Wu

25 papers receiving 968 citations

Hit Papers

Targeting Oxidative Stress and Inflammation to Prevent Is... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting Oxidative Stress and Inflammation to Prevent Ischemia-Reperfusion Injury
    2020 364 citations Liquan Wu, Xiaoxing Xiong et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liquan Wu China 15 430 169 156 150 126 27 984
Rong Xie China 18 468 1.1× 131 0.8× 184 1.2× 139 0.9× 73 0.6× 67 965
Inbo Han South Korea 20 445 1.0× 84 0.5× 127 0.8× 303 2.0× 136 1.1× 27 1.1k
Debayon Paul United States 14 379 0.9× 241 1.4× 121 0.8× 102 0.7× 107 0.8× 17 866
Jinxia Hu China 24 853 2.0× 197 1.2× 292 1.9× 67 0.4× 71 0.6× 74 1.6k
Simona Delle Monache Italy 28 682 1.6× 55 0.3× 233 1.5× 91 0.6× 114 0.9× 54 1.7k
Yu‐Peng Liu Taiwan 21 725 1.7× 107 0.6× 227 1.5× 57 0.4× 140 1.1× 55 1.4k
Jungsul Lee South Korea 20 646 1.5× 66 0.4× 190 1.2× 66 0.4× 129 1.0× 54 1.2k
Xiaojia Huang China 19 491 1.1× 153 0.9× 117 0.8× 43 0.3× 63 0.5× 33 1.0k

Countries citing papers authored by Liquan Wu

Since Specialization
Citations

This map shows the geographic impact of Liquan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liquan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liquan Wu more than expected).

Fields of papers citing papers by Liquan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liquan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liquan Wu. The network helps show where Liquan Wu may publish in the future.

Co-authorship network of co-authors of Liquan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Liquan Wu. A scholar is included among the top collaborators of Liquan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liquan Wu. Liquan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cheng, Jing, Yu Han, Zhifeng Zhang, et al.. (2024). Mxene-bpV plays a neuroprotective role in cerebral ischemia-reperfusion injury by activating the Akt and promoting the M2 microglial polarization signaling pathways. Journal of Materials Science Materials in Medicine. 35(1). 42–42. 2 indexed citations
3.
Yuwen, Lihui, Xinyi Li, Liquan Wu, Yi Luo, & Shao Su. (2023). Construction of a point-of-care electrochemical biosensor for Escherichia coli 16S rRNA analysis based on MoS2 nanoprobes. The Analyst. 148(24). 6292–6296. 8 indexed citations
4.
Cheng, Jing, Yanqin Fan, Wenfei Zhang, et al.. (2022). Overexpressing SIRT6 can Attenuate the Injury of Intracerebral Hemorrhage by Down-Regulating NF-kB. NeuroMolecular Medicine. 25(1). 53–63. 10 indexed citations
5.
Wu, Li‐Hao, Mei-Hui Chen, Yuan Yu, et al.. (2020). The correlation between intestinal mucosal lesions and hepatic dysfunction in patients without chronic liver disease. Medicine. 99(7). e18837–e18837. 4 indexed citations
6.
Yang, Jian, Long Wang, Xu Zhou, et al.. (2020). Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme. Frontiers in Genetics. 11. 253–253. 14 indexed citations
7.
Glaser, Talita, Inbo Han, Liquan Wu, & Xiang Zeng. (2017). Targeted Nanotechnology in Glioblastoma Multiforme. Frontiers in Pharmacology. 8. 166–166. 128 indexed citations
8.
He, Yuanzhou, Xiaohong Wu, Yan Cao, et al.. (2016). Daidzein exerts anti-tumor activity against bladder cancer cells via inhibition of FGFR3 pathway. Neoplasma. 63(4). 523–531. 34 indexed citations
9.
Wu, Tingfeng, Yuntao Li, Baohui Liu, et al.. (2016). Expression of Ferritin Light Chain (FTL) Is Elevated in Glioblastoma, and FTL Silencing Inhibits Glioblastoma Cell Proliferation via the GADD45/JNK Pathway. PLoS ONE. 11(2). e0149361–e0149361. 48 indexed citations
10.
Liu, Baohui, Xi Lin, Xiangsheng Yang, et al.. (2015). Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity. Cancer Medicine. 4(9). 1404–1416. 22 indexed citations
11.
Liu, Baohui, Zhentao Guo, Huimin Dong, et al.. (2015). LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2. Brain Research. 1611. 93–100. 21 indexed citations
12.
Wei, Yi, Haitao Xu, Daofeng Tian, et al.. (2015). Photodynamic therapy mediated by 5-aminolevulinic acid suppresses gliomas growth by decreasing the microvessels. Journal of Huazhong University of Science and Technology [Medical Sciences]. 35(2). 259–264. 14 indexed citations
13.
Cai, Qiang, Zhibiao Chen, Ping Song, et al.. (2015). Co-transplantation of hippocampal neural stem cells and astrocytes and microvascular endothelial cells improve the memory in ischemic stroke rat.. PubMed. 8(8). 13109–17. 19 indexed citations
14.
Liu, Baohui, Daofeng Tian, Liquan Wu, et al.. (2014). LRIG1 Improves Chemosensitivity Through Inhibition of BCL-2 and MnSOD in Glioblastoma. Cell Biochemistry and Biophysics. 71(1). 27–33. 2 indexed citations
15.
Xu, Haitao, et al.. (2014). Down-Regulation of MRP1 Expression in C6/VP16 Cells by Chitosan-MRP1-siRNA Nanoparticles. Cell Biochemistry and Biophysics. 72(1). 227–233. 6 indexed citations
16.
Liu, Baohui, Qianxue Chen, Daofeng Tian, et al.. (2013). BMP4 reverses multidrug resistance through modulation of BCL-2 and GDNF in glioblastoma. Brain Research. 1507. 115–124. 21 indexed citations
17.
Chen, Qianxue, Daofeng Tian, Liquan Wu, et al.. (2011). Indution of apoptosis of U251 cells by blocking STAT3 signaling pathways with MS-275. Zhonghua shiyan waike zazhi. 28(2). 252–254. 1 indexed citations
18.
Liu, Baohui, Daofeng Tian, Wei Yi, et al.. (2010). Effect of Bone Morphogenetic Protein 4 in the Human Brain Glioma Cell Line U251. Cell Biochemistry and Biophysics. 58(2). 91–96. 8 indexed citations
19.
Sundaresan, Narayan, et al.. (1995). Surgical treatment of spinal cord compression from epidural metastasis.. Journal of Clinical Oncology. 13(9). 2330–2335. 101 indexed citations
20.
Trojanowska, Maria, Liquan Wu, & E. Carwile LeRoy. (1988). Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts.. PubMed. 3(4). 477–81. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rong Xie Breakdown of academic impact, for papers by Inbo Han Breakdown of academic impact, for papers by Debayon Paul Breakdown of academic impact, for papers by Jinxia Hu Breakdown of academic impact, for papers by Simona Delle Monache Breakdown of academic impact, for papers by Yu‐Peng Liu Breakdown of academic impact, for papers by Jungsul Lee Breakdown of academic impact, for papers by Xiaojia Huang
Rankless by CCL
2026